Congestive Heart Failure
A noninvasive measure of baroreflex sensitivity without blood pressure measurement*,**

https://doi.org/10.1067/mhj.2002.121263Get rights and content

Abstract

Background Baroreflex sensitivity (BRS) and heart rate variability (HRV) are attenuated in cardiovascular disease and can give important prognostic information. Conventional measures of BRS require expensive or invasive equipment for the beat-to-beat measure of blood pressure (BP). We examined the possibility of developing a simple protocol that would provide a relatively standardized BP stimulus, which might obviate the need to measure BP beat-by-beat. Methods and Results Fifty-five patients with chronic heart failure (mean age 59 [SD 11] years) and 20 healthy control subjects (mean age 53 [SD 14] years, P not significant) underwent 5-minute recordings of BP (by photoplethysmograph) and R-R interval during 0.1-Hz controlled breathing. The size of the oscillations in BP was the same in the 2 groups (3.6 mm Hg vs 4.1 mm Hg, P =.5). There was, however, a significant difference in the amplitude of the R-R interval oscillations (77 ms vs 31 ms, P <.0001). The amplitude of the R-R interval oscillations correlated strongly with BRS (r = 0.81, P <.0001 with controlled breathing BRS, and r = 0.51, P <.0001 with α index). There was no correlation with the size of BP oscillations (r = −0.13, P not significant with controlled breathing BRS, and r = −0.15, P not significant with α index). In a separate study, a group of 22 young patients (mean age 36 years) with type I diabetes mellitus and 28 healthy control subjects (mean age 39 years) underwent measurement of resting HRV and amplitude of R-R interval oscillations during 0.1-Hz breathing. There was no significant difference in triangular index or low-frequency R-R interval power between the 2 groups. There was, however, a significant difference in the amplitude of R-R interval oscillations during controlled breathing between patients with diabetes and healthy control subjects. Total and high-frequency RR interval variability was also significantly different between the 2 groups. Conclusion During 0.1-Hz breathing, the marked difference in BRS between patients with CHF and age-matched control subjects is the result of smaller R-R interval oscillations. In young patients with diabetes, these R-R interval oscillations are significantly smaller than age-matched control subjects, even when some measures of spontaneous HRV are not different between groups. Breathing at 0.1 Hz provides a standard BP stimulus and concentrates spectral power of heart rate at one frequency, enabling simple evaluation of BRS even when BP measurement is not available. (Am Heart J 2002;143:441-7.)

Section snippets

CHF patients and age-matched control subjects

Fifty-five patients with CHF were recruited from a specialist clinic. They were diagnosed on the basis of clinical assessment (a history of dyspnea and symptomatic exercise intolerance with previous signs of pulmonary congestion or peripheral edema) and/or evidence of left ventricular dysfunction from radionucleide ventriculogram or echocardiogram. Patients with atrial fibrillation, permanent pacemakers, more than 2 ectopic beats per minute, or clinical instability within the preceding 3 months

Patient characteristics

The average age of the 55 patients with CHF was 59 (SD 11) years. Forty-four had heart failure from coronary artery disease, 9 had idiopathic dilated cardiomyopathy, and 2 had heart failure from mitral regurgitation. The mean ejection fraction was 30% (SD 15%, n = 33). Eight patients were in NYHA class I, 41 in class II, and 6 in class III. Fifty-two of the patients were taking an angiotensin-converting enzyme inhibitor or angiotensin II receptor antagonist, and none were receiving a β-blocker.

Discussion

This study has shown that when measuring BRS by monitoring beat-by-beat R-R interval and BP during slow breathing at 0.1 Hz, almost all the information relevant to determining the BRS is carried within the R-R interval signal. This is true for patients with CHF and in age-matched healthy control subjects. In patients with autonomic dysfunction as a result of diabetes mellitus, there is depression of the amplitude of oscillation in the R-R interval. This measure is as good at distinguishing

References (24)

  • M Pagani et al.

    Changes in autonomic regulation induced by physical training in mild hypertension

    Hypertension

    (1988)
  • P Ponikowski et al.

    Augmented peripheral chemosensitivity as a potential input to baroreflex impairment and autonomic imbalance in chronic heart failure

    Circulation

    (1997)
  • Cited by (0)

    *

    L. C. D. is supported by the Robert Luff Fellowship, H. C. and D. P. F. by the British Heart Foundation, M. P. by the Wellcome Foundation, and A. J. S. C. by the Viscount Royston Trust.

    **

    Reprint requests: L. Ceri Davies, BSc, MRCP, Heart Failure Unit, Royal Brompton Hospital, Sydney St, London SW3 6NP, UK. [email protected]

    View full text